MedTrace Logo

Effects of Bifidobacterium Longum BB536 on Incidence of Acute Diarrhea and/or Respiratory- Related Illnesses in Children

NCT02434042 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 520

Last updated 2017-11-06

No results posted yet for this study

Summary

This project aims to study the benefits of probiotics namely Bifidobacterium longum BB536 in prevention of acute diarrhea and/or respiratory-related illnesses, which are found common among children in Malaysia aged from 2 to 6 years.

Conditions

  • Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

BB536

Intervention consists of daily administration of 1g probiotic Bifidobacterium longum BB536, administer daily for five days a week at a fixed dosage of 9 log CFU/day for BB536 and continue for 10 months.

OTHER

Placebo

Intervention consists of daily administration of 1g of 100% dextrin, administer daily for five days a week and continue for 10 months.

Sponsors & Collaborators

  • Morinaga Milk Industry Co., LTD

    collaborator INDUSTRY

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Min Tze Liong, PhD · Universiti Sains Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2016-02-28
Completion
2016-02-28

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02434042 on ClinicalTrials.gov